Global Congress on Bladder Cancer 2018

Global Congress on Bladder Cancer 2018

  • Congress highlights 2018: what you need to remember according to the clinical oncologist
    Nicholas James
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • What’s in the boiling pot of NMIBC - case discussion
    Marek Babjuk, Badrinath Konety, Luis Martínez-Piñeiro
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Novel endoscopic imaging
    Sia Daneshmand
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Role of IO in NMIBC
    Badrinath Konety
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • IO in advanced disease
    Petros Grivas
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Role of chemotherapy
    Ignacio Durán
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Variant histology: what pathology can tell you
    Eva Comperat
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Multidisciplinary case discussion on patients with rare disease characteristics
    Eva Comperat, Maria De Santis, Georgios Gakis, Peter Hoskin
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Has the molecular subtype impact on patient outcomes?
    Francisco X. Real
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Robotic cystectomy: what's the evidence?
    Peter Wiklund
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • What is the role of novel, non-IO agents in MIBC?
    Michiel van der Heijden
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Adjuvant RT after cystectomy: a good idea?
    Valérie Fonteyne
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Debate: TURBT should be a redundant treatment in patients with MIBC
    Jürgen Gschwend, Nicholas James
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Overcoming barriers to progress in NMIBC - Where are we in 2018 and where will we be in 5 years?
    Ashish Kamat
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Congress highlights 2018: what you need to remember according to the urologist
    Jacques Irani
    Global Congress on Bladder Cancer 2018
    20 Sep 2018
  • Controlling symptoms in metastatic bladder cancer
    Sergio Bracarda
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • Personalised RT
    Ananya Choudhury
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • UTUC - Adjuvant chemotherapy for all patients?
    Alison Birtle
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • How may diagnostic imaging influence the treatment of advanced bladder cancer?
    Nigel Cowan
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • Case discussion: the role of local control in MIBC and oligometastatic disease
    Peter Hoskin, Jacques Irani
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • Vision on the future - patient representative
    Caroline Raw
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • Vision on the future - medical oncology
    Petros Grivas
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • Vision on the future - radiation oncology
    Xavier Maldonado
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • Vision on the future - urology
    María J. Ribal
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • The perfect lymph node dissection
    Jürgen Gschwend
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • Practical considerations: what every clinician should know about immuno-oncology
    Margitta Retz
    Global Congress on Bladder Cancer 2018
    21 Sep 2018
  • Perioperative chemotherapy in cisplatin "unfit" patients
    Maria De Santis
    Global Congress on Bladder Cancer 2018
    21 Sep 2018

We are sorry, but your browser is out of date.

An additional plug-in or an upgrade of your browser is required to play this video.